PAR paradigm biopharmaceuticals limited..

Ann: March 2025 Quarterly Activities Report & Appendix 4C, page-8

  1. 1,358 Posts.
    lightbulb Created with Sketch. 314
    Hi Aviza. In a way I would rather see debt funding or convertibles or maybe a small region deal to cover our Phase 3. If it was a total BP deal for distribution etc then we'd be getting a lower price than we would after a decent interim result, which we will all be sweating on.

    I am hopeful that we will see two types of funding in the next three years. The first to get us through or largely through Phase 3 via some debt/more dilution and the second a big fat lump and high royalties for distribution. Reason I am hopeful? Because I'm still invested in PAR and therefore I have to be lol - the alternative is deep depression given some of my buy prices!

    We all have heard about the data room interest, multiple parties etc. I am hopeful that this is BP for the long-term deals not just short-term funding.

    We will inevitably get diluted more and I can handle that if the final payoff is bigger.

    Rose coloured glasses, with a bit of mud on them maybe.

    Violin
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
31.0¢
Change
0.020(6.90%)
Mkt cap ! $120.7M
Open High Low Value Volume
29.0¢ 31.0¢ 28.0¢ $97.62K 331.4K

Buyers (Bids)

No. Vol. Price($)
2 74197 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 54675 2
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.